Acme United (ACU)
Market Price (8/13/2026): $59.28 | Market Cap: $226.4 MilSector: Consumer Staples | Industry: Household Products
Acme United (ACU)
Market Price (8/13/2026): $59.28Market Cap: $226.4 MilSector: Consumer StaplesIndustry: Household Products
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.4%, FCF Yield is 6.8% Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12% Low stock price volatilityVol 12M is 35% Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Outdoor & Recreational Lifestyles. Themes include First Aid & Personal Safety, and Outdoor Tools & Equipment. | Trading close to highsDist 52W High is -0.5%, Dist 3Y High is -0.5% | Key risksACU key risks include [1] supply chain vulnerability to tariffs on Chinese goods, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.4%, FCF Yield is 6.8% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12% |
| Low stock price volatilityVol 12M is 35% |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Outdoor & Recreational Lifestyles. Themes include First Aid & Personal Safety, and Outdoor Tools & Equipment. |
| Trading close to highsDist 52W High is -0.5%, Dist 3Y High is -0.5% |
| Key risksACU key risks include [1] supply chain vulnerability to tariffs on Chinese goods, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Updated on 8/12/2026
Acme United (ACU) stock has gained about 45% since 4/30/2026 because of the following key factors:
1. Acme United reported robust fiscal Q2 2026 earnings, significantly surpassing analyst expectations. The company posted diluted earnings per share (EPS) of $1.22, which was a substantial 106.8% beat compared to the analyst forecast of $0.59. Net sales for the quarter, which ended June 30, 2026, increased by 16% to $62.7 million, up from $54.0 million in fiscal Q2 2025.
2. The company experienced strong revenue growth driven by its My Medic acquisition and organic expansion in key segments. The 16% increase in fiscal Q2 2026 net sales included an 8% comparable sales growth excluding the My Medic acquisition, indicating healthy demand across traditional product categories. The acquisition of the direct-to-consumer My Medic business, completed on January 15, 2026, for $18.5 million, significantly boosted the first aid and medical segments and contributed to an improved gross margin of 42.6% in fiscal Q2 2026, compared to 41.0% in the prior year.
Show more
Acme United (ACU) stock has gained about 45% since 4/30/2026 because of the following key factors:
1. Acme United reported robust fiscal Q2 2026 earnings, significantly surpassing analyst expectations. The company posted diluted earnings per share (EPS) of $1.22, which was a substantial 106.8% beat compared to the analyst forecast of $0.59. Net sales for the quarter, which ended June 30, 2026, increased by 16% to $62.7 million, up from $54.0 million in fiscal Q2 2025.
2. The company experienced strong revenue growth driven by its My Medic acquisition and organic expansion in key segments. The 16% increase in fiscal Q2 2026 net sales included an 8% comparable sales growth excluding the My Medic acquisition, indicating healthy demand across traditional product categories. The acquisition of the direct-to-consumer My Medic business, completed on January 15, 2026, for $18.5 million, significantly boosted the first aid and medical segments and contributed to an improved gross margin of 42.6% in fiscal Q2 2026, compared to 41.0% in the prior year.
Show more
Updated on 8/12/2026
Acme United (ACU) stock has gained about 45% since 4/30/2026 because of the following key factors:
1. Acme United reported robust fiscal Q2 2026 earnings, significantly surpassing analyst expectations. The company posted diluted earnings per share (EPS) of $1.22, which was a substantial 106.8% beat compared to the analyst forecast of $0.59. Net sales for the quarter, which ended June 30, 2026, increased by 16% to $62.7 million, up from $54.0 million in fiscal Q2 2025.
2. The company experienced strong revenue growth driven by its My Medic acquisition and organic expansion in key segments. The 16% increase in fiscal Q2 2026 net sales included an 8% comparable sales growth excluding the My Medic acquisition, indicating healthy demand across traditional product categories. The acquisition of the direct-to-consumer My Medic business, completed on January 15, 2026, for $18.5 million, significantly boosted the first aid and medical segments and contributed to an improved gross margin of 42.6% in fiscal Q2 2026, compared to 41.0% in the prior year.
3. Acme United enhanced its financial flexibility and liquidity with a new $65 million syndicated credit facility. On July 15, 2026, the company secured a new credit facility, replacing its former arrangement and extending financing through 2029. This new facility strengthens the company's liquidity, supporting ongoing operations and potential future growth and acquisition strategies.
4. Increased institutional investor interest signaled growing market confidence in the company. Institutional ownership remained substantial at 62.1% during fiscal Q2 2026. Several prominent institutional investors, including Bank of America, JPMorgan Chase, Mirae Asset Global ETFs, Raymond James, and the New York State Common Retirement Fund, either initiated new positions or significantly increased their existing holdings in Acme United during this period.
Show less
Acme United (ACU) stock has gained about 45% since 4/30/2026 because of the following key factors:
1. Acme United reported robust fiscal Q2 2026 earnings, significantly surpassing analyst expectations. The company posted diluted earnings per share (EPS) of $1.22, which was a substantial 106.8% beat compared to the analyst forecast of $0.59. Net sales for the quarter, which ended June 30, 2026, increased by 16% to $62.7 million, up from $54.0 million in fiscal Q2 2025.
2. The company experienced strong revenue growth driven by its My Medic acquisition and organic expansion in key segments. The 16% increase in fiscal Q2 2026 net sales included an 8% comparable sales growth excluding the My Medic acquisition, indicating healthy demand across traditional product categories. The acquisition of the direct-to-consumer My Medic business, completed on January 15, 2026, for $18.5 million, significantly boosted the first aid and medical segments and contributed to an improved gross margin of 42.6% in fiscal Q2 2026, compared to 41.0% in the prior year.
3. Acme United enhanced its financial flexibility and liquidity with a new $65 million syndicated credit facility. On July 15, 2026, the company secured a new credit facility, replacing its former arrangement and extending financing through 2029. This new facility strengthens the company's liquidity, supporting ongoing operations and potential future growth and acquisition strategies.
4. Increased institutional investor interest signaled growing market confidence in the company. Institutional ownership remained substantial at 62.1% during fiscal Q2 2026. Several prominent institutional investors, including Bank of America, JPMorgan Chase, Mirae Asset Global ETFs, Raymond James, and the New York State Common Retirement Fund, either initiated new positions or significantly increased their existing holdings in Acme United during this period.
Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
The 46.7% change in ACU stock from 4/30/2026 to 8/12/2026 was primarily driven by a 52.7% change in the company's P/E Multiple.| (LTM values as of) | 4302026 | 8122026 | Change |
|---|---|---|---|
| Stock Price ($) | 40.63 | 59.59 | 46.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 197 | 212 | 7.7% |
| Net Income Margin (%) | 5.2% | 4.6% | -10.5% |
| P/E Multiple | 15.2 | 23.2 | 52.7% |
| Shares Outstanding (Mil) | 4 | 4 | -0.4% |
| Cumulative Contribution | 46.7% |
Market Drivers
4/30/2026 to 8/12/2026| Return | Correlation | |
|---|---|---|
| ACU | 46.7% | |
| Market (SPY) | 7.5% | -22.2% |
| Sector (XLP) | 0.9% | 15.3% |
Fundamental Drivers
The 43.6% change in ACU stock from 1/31/2026 to 8/12/2026 was primarily driven by a 47.2% change in the company's P/E Multiple.| (LTM values as of) | 1312026 | 8122026 | Change |
|---|---|---|---|
| Stock Price ($) | 41.50 | 59.59 | 43.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 195 | 212 | 8.5% |
| Net Income Margin (%) | 5.1% | 4.6% | -9.7% |
| P/E Multiple | 15.8 | 23.2 | 47.2% |
| Shares Outstanding (Mil) | 4 | 4 | -0.5% |
| Cumulative Contribution | 43.6% |
Market Drivers
1/31/2026 to 8/12/2026| Return | Correlation | |
|---|---|---|
| ACU | 43.6% | |
| Market (SPY) | 11.9% | 5.2% |
| Sector (XLP) | 2.5% | 18.3% |
Fundamental Drivers
The 50.5% change in ACU stock from 7/31/2025 to 8/12/2026 was primarily driven by a 56.7% change in the company's P/E Multiple.| (LTM values as of) | 7312025 | 8122026 | Change |
|---|---|---|---|
| Stock Price ($) | 39.59 | 59.59 | 50.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 195 | 212 | 8.2% |
| Net Income Margin (%) | 5.1% | 4.6% | -9.7% |
| P/E Multiple | 14.8 | 23.2 | 56.7% |
| Shares Outstanding (Mil) | 4 | 4 | -1.7% |
| Cumulative Contribution | 50.5% |
Market Drivers
7/31/2025 to 8/12/2026| Return | Correlation | |
|---|---|---|
| ACU | 50.5% | |
| Market (SPY) | 23.3% | 14.6% |
| Sector (XLP) | 8.8% | 17.7% |
Fundamental Drivers
The 105.1% change in ACU stock from 7/31/2023 to 8/12/2026 was primarily driven by a 185.3% change in the company's Net Income Margin (%).| (LTM values as of) | 7312023 | 8122026 | Change |
|---|---|---|---|
| Stock Price ($) | 29.06 | 59.59 | 105.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 196 | 212 | 7.7% |
| Net Income Margin (%) | 1.6% | 4.6% | 185.3% |
| P/E Multiple | 32.2 | 23.2 | -28.0% |
| Shares Outstanding (Mil) | 4 | 4 | -7.3% |
| Cumulative Contribution | 105.1% |
Market Drivers
7/31/2023 to 8/12/2026| Return | Correlation | |
|---|---|---|
| ACU | 105.1% | |
| Market (SPY) | 74.7% | 20.8% |
| Sector (XLP) | 21.0% | 10.8% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| ACU Return | 13% | -34% | 100% | -12% | 10% | 44% | 110% |
| Peers Return | 32% | -11% | 21% | 5% | -20% | 3% | 21% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 13% | 106% |
Monthly Win Rates [3] | |||||||
| ACU Win Rate | 50% | 17% | 75% | 25% | 50% | 88% | |
| Peers Win Rate | 54% | 40% | 48% | 50% | 33% | 55% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| ACU Max Drawdown | -33% | -38% | -32% | -33% | -20% | -12% | |
| Peers Max Drawdown | -16% | -28% | -19% | -22% | -31% | -15% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: IPAR, CENT, BIOT, CL, KMB.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/12/2026 (YTD)
How Low Can It Go
| Event | ACU | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -30.2% | -24.5% |
| % Gain to Breakeven | 43.3% | 32.4% |
| Time to Breakeven | 290 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -25.9% | -33.7% |
| % Gain to Breakeven | 35.0% | 50.9% |
| Time to Breakeven | 121 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -36.2% | -19.2% |
| % Gain to Breakeven | 56.6% | 23.8% |
| Time to Breakeven | 132 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -24.7% | -12.2% |
| % Gain to Breakeven | 32.8% | 13.9% |
| Time to Breakeven | 105 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -17.3% | -6.8% |
| % Gain to Breakeven | 20.9% | 7.3% |
| Time to Breakeven | 42 days | 15 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -10.2% | -17.9% |
| % Gain to Breakeven | 11.4% | 21.8% |
| Time to Breakeven | 130 days | 123 days |
In The Past
Acme United's stock fell -3.0% during the 2025 US Tariff Shock. Such a loss loss requires a 3.1% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | ACU | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -30.2% | -24.5% |
| % Gain to Breakeven | 43.3% | 32.4% |
| Time to Breakeven | 290 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -25.9% | -33.7% |
| % Gain to Breakeven | 35.0% | 50.9% |
| Time to Breakeven | 121 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -36.2% | -19.2% |
| % Gain to Breakeven | 56.6% | 23.8% |
| Time to Breakeven | 132 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -24.7% | -12.2% |
| % Gain to Breakeven | 32.8% | 13.9% |
| Time to Breakeven | 105 days | 62 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -57.1% | -53.4% |
| % Gain to Breakeven | 132.9% | 114.4% |
| Time to Breakeven | 1519 days | 1085 days |
In The Past
Acme United's stock fell -3.0% during the 2025 US Tariff Shock. Such a loss loss requires a 3.1% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Acme United (ACU)
Acme United Corporation (ACU), established in 1867, is a diversified supplier of essential products across two main categories: first aid and safety solutions, and a comprehensive range of cutting, sharpening, and measuring tools. The company operates globally, serving school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and beyond.
The company's product portfolio includes prominent brands catering to various needs. For cutting, sharpening, and measuring, Acme United offers Westcott brand scissors, rulers, and craft products; Clauss cutting tools; Camillus and Cuda knives and fishing tools; and DMT sharpening tools. In the first aid and safety segment, it provides First Aid Only kits and safety solutions, PhysiciansCare portable eyewash and over-the-counter medications, Spill Magic clean-up solutions, and a variety of antiseptic and medical wipes under brands like First Aid Central and Med-Nap.
Acme United reaches its diverse customer base through a broad distribution network. This includes direct sales, independent manufacturer representatives, and various channels such as wholesale and retail stationery distributors, office supply superstores, school and industrial distributors, hardware chains, mass market and e-commerce retailers, and direct sales via its own websites.
AI Analysis | Feedback
Here are 1-2 brief analogies for Acme United (ACU):
-
A smaller **Newell Brands**, but specializing in a portfolio of cutting tools, first aid, and safety products for home, office, and industrial markets.
-
Like **3M**, but with a more concentrated focus on consumer and industrial cutting tools, first aid, and safety essentials rather than a broad array of materials science and industrial innovations.
AI Analysis | Feedback
- Cutting Tools: A diverse range of scissors, shears, knives, and specialized cutting tools for various applications and markets.
- Sharpening Tools: Products designed for sharpening knives and other cutting implements.
- Measuring Products: Includes rulers and other precision devices for measurement.
- First Aid Kits and Supplies: Comprehensive kits, refills, and safety supplies covering general, emergency, and specialized first aid needs.
- Over-the-Counter Medications: Common pain relief and fever-reducing medications like aspirin, acetaminophen, and ibuprofen.
- Eyewash and Antiseptic Solutions: Portable eyewash solutions and a variety of antiseptic wipes, pads, and cleaning wipes for hygiene and wound care.
- Spill Clean-up Solutions: Products specifically formulated for the safe and effective management and clean-up of bodily fluids and other spills.
- Craft and Hobby Supplies: Items such as glue guns, lettering products, and other materials for creative and hobby projects.
- Fishing Tools and Accessories: Specialized tools, knives, nets, and gaffs designed for fishing activities.
AI Analysis | Feedback
Acme United Corporation (ACU) primarily sells its products to other companies. The provided background description does not list specific names of individual customer companies. However, it identifies the major categories of businesses that serve as its customers. These include:
- Office supply super stores: For example, public companies such as Office Depot (ODP) operate in this category.
- Mass market and e-commerce retailers: Examples include public companies like Walmart (WMT), Target (TGT), and Amazon (AMZN).
- Hardware chains: Public companies such as The Home Depot (HD) and Lowe's (LOW) are prominent in this sector.
- Wholesale, contract, and retail stationery distributors
- School supply distributors
- Industrial distributors
- Wholesale florists
AI Analysis | Feedback
null
AI Analysis | Feedback
Walter C. Johnsen, Chairman and Chief Executive Officer
Walter C. Johnsen has served as Chairman and Chief Executive Officer of Acme United Corporation since November 30, 1995. He initially joined the company as Executive Vice President in January 1995 and briefly served as Chief Financial Officer from March to June 1996. Before joining Acme United, Mr. Johnsen was Vice Chairman and a principal of Marshall Products, Inc., a medical supply distributor, which was sold to Omron Corporation for $25 million in 1990. Following the leveraged buyout of Marshall Partners, he became a special limited partner at Harvest Partners, a private equity firm. He also founded Johnsen Properties, a real estate investment company.
Paul G. Driscoll, Vice President and Chief Financial Officer, Secretary and Treasurer
Paul G. Driscoll has held the positions of Vice President and Chief Financial Officer, Secretary and Treasurer since October 2, 2002. He began his tenure at Acme United as Director International Finance on March 19, 2001. Prior to his time at Acme United, Mr. Driscoll was employed by Ernest and Julio Gallo Winery from 1997 to 2001, including a two-year period as Director of Finance and Operations in Japan. Before that, he held various progressively responsible finance positions at Sterling Winthrop Inc. in New York City and Sanofi S.A. in France.
Brian S. Olschan, President and Chief Operating Officer
Brian S. Olschan has served as President and Chief Operating Officer of Acme United Corporation since January 1, 2007, and as President and Chief Operating Officer since January 23, 1999. He previously served as Senior Vice President-Sales and Marketing from September 1996 to February 1999. From 1984 to 1996, Mr. Olschan was employed by General Cable Corporation, where he held several executive positions, including Vice President and General Manager of the Cordset and Assembly Business from 1994 to 1996.
AI Analysis | Feedback
The key risks to Acme United's business include:
- The market for first aid, safety, cutting, sharpening, and measuring products is highly competitive. Acme United faces significant pricing pressure and competition from numerous existing players, including larger diversified companies and private label brands, which could impact its market share and profitability.
- Acme United's reliance on a diverse network of wholesale, contract, retail, and e-commerce distribution channels exposes it to risks associated with the health and evolving dynamics of these channels. Changes in retailer consolidation, shifts in purchasing patterns, or the increasing dominance of e-commerce platforms could impact sales and distribution reach.
- Demand for Acme United's products, which serve the school, home, office, hardware, sporting goods, and industrial markets, is sensitive to general economic conditions. Economic downturns or reduced consumer and business spending could lead to decreased demand and sales across its product categories.
AI Analysis | Feedback
null
AI Analysis | Feedback
Acme United Corporation operates within several addressable markets related to its first aid and safety, cutting, sharpening, and measuring products.
First Aid and Safety Products
- The global first aid market was valued at approximately USD 4.66 billion in 2023 and is projected to reach USD 6.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.48% from 2024 to 2032.
- Another report states the global first aid market size was USD 4.77 billion in 2024 and is projected to reach USD 6.18 billion by 2030, with a CAGR of 4.4% from 2025 to 2030.
- The North American first aid market held the largest share of 47.0% in 2024. The U.S. first aid market has shown growth from USD 1.59 billion in 2023 to an estimated USD 2.33 billion by 2032, indicating a 4.32% increase.
- The global first aid kits market was valued at around USD 217 million in 2022 and is estimated to reach over USD 359 million by 2032. The U.S. first aid kits industry is anticipated to reach around USD 139 million by 2032.
Cutting Products
- The global cutting tools market was valued at USD 9.50 billion in 2022 and is expected to reach USD 13.26 billion by 2028, growing at a CAGR of 5.72% from 2022 to 2028. Other estimates place the global cutting tools market at USD 24.23 billion in 2024, projected to grow to USD 37.00 billion by 2032 at a CAGR of 6.4%. Another source indicates a value of USD 83.8 billion in 2024, projected to reach USD 135.98 billion by 2035 at a CAGR of 4.5%.
- The U.S. cutting tools market has a total available market of about USD 5 billion. The U.S. cutting tools market was worth over USD 2.6 billion in 2024.
Sharpening Products
- The global tool sharpener market size is likely to be valued at USD 1.7 billion in 2026 and is expected to reach USD 2.6 billion by 2033, growing at a CAGR of 6.3%. North America is anticipated to be the leading region, accounting for a market share of 35% in 2026.
- The global knife sharpener market was valued at USD 796.69 million in 2023 and is anticipated to exceed USD 1477.15 million by 2033, growing at a CAGR of 6.37%. Another source estimates the global knife sharpener market at about USD 0.94 billion in 2026, projected to reach USD 1.42 billion by 2035 at a CAGR of 4.68%.
- The global knife sharpener and honer market size was valued at USD 638 million in 2023 and is estimated to grow at a CAGR of over 4.6% from 2024 to 2032. The U.S. knife sharpener and honer market accounted for approximately USD 134 million in 2023.
Measuring Products
- The global measuring instrument market size is expected to grow from USD 56.63 billion in 2025 to USD 61.56 billion in 2026, with a CAGR of 8.7%. It is projected to reach USD 84.94 billion by 2030 at a CAGR of 8.4%.
- The global measuring tools market size was estimated at USD 32.6 billion in 2023 and is projected to reach USD 41.2 billion in 2030 at a CAGR of 4.8%.
- The global plain measuring tools market size was USD 1371.43 million in 2021 and is projected to reach USD 2324.71 million by 2033, growing at a CAGR of 4.496% from 2025 to 2033. North America holds a commanding 28.0% of the global market, with the United States accounting for 18.27% of the global market share in 2025.
- The global precision measuring tools market size is projected to grow from USD 6.5 billion in 2023 to USD 9.8 billion by 2032, at a CAGR of 4.8%. Other estimates for the global precision measuring tools market size show it was USD 9.58 billion in 2021 and is projected to reach USD 16.58 billion by 2033, growing at a CAGR of 4.672%. North America dominates this market, holding a substantial 40% market share in 2023. The U.S. precision measuring tools market sales revenue was USD 2.74 billion in 2021 and is projected to reach USD 4.42 billion by 2033.
- The global laser measuring instrument market was valued at USD 3.8 billion in 2023 and is estimated to grow at a CAGR of 5% during 2024 and 2032. North America laser measuring instrument market size surpassed USD 800 million in 2023 and is likely to exceed USD 1.3 billion by 2032.
AI Analysis | Feedback
Acme United Corporation (ACU) is expected to drive future revenue growth over the next 2-3 years through several key strategies:
- Expansion in First Aid and Medical Products: The company is strategically focused on its first aid and medical products segment, which significantly contributed to its performance in 2025 and is projected to lead future growth. This includes the introduction of innovative solutions like SmartCompliance first aid cabinets, featuring RFID technology for automatic refill replenishment, which offers cost savings and ensures compliance. Acquisitions such as Elite First Aid in May 2024 and My Medic in January 2026 further strengthen and expand Acme United's product portfolio within the premium first aid and emergency medical sectors, as well as its direct-to-consumer channel. This segment is increasingly becoming the primary revenue stream, accounting for roughly two-thirds of total corporate revenues.
- Strategic Acquisitions: Acme United has a successful history of opportunistic acquisitions, which are central to its growth strategy. The company views the current tariff environment as a strategic opportunity to pursue further acquisitions, particularly targeting competitors facing challenges due to increased import costs. Recent examples include the acquisitions of Elite First Aid and My Medic, which enhance product offerings and broaden distribution.
- International Market Expansion: Strong performance in international markets, particularly the surge in European net sales by 31% and Canadian sales by 14% in Q4 2025, especially in the first aid product segment, indicates significant growth potential from expanding global reach. The company is also investing in expanded international sourcing.
- Product Innovation and Diversification into New Categories: Acme United emphasizes a strategic focus on innovation and the expansion of its product lines. This includes the ongoing development of products within its existing portfolio, such as the expansion of Westcott ceramic cutters and new craft planograms. Furthermore, the company is strategically entering new product categories, with its Westcott cutting and DMT sharpening businesses looking to expand into the kitchen and household markets in 2025.
- Enhanced Operational Efficiencies and E-commerce Growth: While contributing to profitability, efforts to enhance operational efficiencies and cost management also support overall growth by freeing up resources for investment. This includes strategic investments in automation that improve efficiency and margins. Additionally, leveraging the e-commerce channel, as seen with the My Medic acquisition that expands the direct-to-consumer reach, presents a significant avenue for growth.
AI Analysis | Feedback
Capital Allocation Decisions for Acme United (ACU) (Last 3-5 Years)
Share Repurchases
- Acme United did not repurchase any shares of its Common Stock during the twelve months ended December 31, 2024.
- As of December 31, 2025, 160,365 shares remained authorized for repurchase under a program initially announced in 2019.
Share Issuance
- As of February 28, 2025, there were 3,754,498 shares of Acme United's $2.50 par value Common Stock outstanding.
- By March 6, 2026, the number of outstanding shares increased slightly to 3,808,225.
Outbound Investments
- Acme United acquired the assets of Live Safely Products, LLC (d/b/a "Safety Made"), a manufacturer of first aid kits for the promotional products industry, which had approximately $4.9 million in revenues in 2021.
- The company acquired Hawktree Solutions out of bankruptcy in late 2023.
- In 2025, Acme United acquired a line of cutting and sharpening tools in Germany for $1.6 million, which had approximately $2 million in annual revenue.
- In January 2026, Acme United acquired the assets of My Medic for $18.7 million ($14.6 million paid at closing, $4.1 million contingent), a leading direct-to-consumer supplier of advanced first aid and bleed control products with approximately $19 million in 2025 revenue.
Capital Expenditures
- In May 2025, Acme United invested approximately $650,000 to install the first robotic system in its Rocky Mount, North Carolina plant to process antiseptic packets, and a second system was ordered for its Vancouver, Washington first aid plant.
- In July 2025, the company purchased a new 78,000 square foot facility in Tennessee for $6 million to expand its Spill Magic production capacity.
- Overall in 2025, Acme United invested in robotics across three U.S. sites to improve productivity and ordered equipment to automate its Spill Magic powder manufacturing process, with completion expected in 2026.
Peer Outperformance in Household Products
ACU has outperformed 95% of its 19 Household Products peers over 5Y. Household Products ranks 9th of 12 industries in Consumer Staples by median 5Y return. The sector’s gains have largely come from elsewhere.
Share of Household Products constituents that ACU has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
1Y
95%
of 20 industry peers · 39.4% return
3Y
95%
of 19 industry peers · 66.1% return
5Y
95%
of 19 industry peers · 69.1% return
No Household Products peer with a comparable growth profile has beaten ACU by more than 20pp over 5Y.
Median price return by industry across the Consumer Staples sector, ranked by 5Y. Household Products is ACU's own industry. Use this to see which corners of the sector have carried the returns.
| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Food Distributors | 8 | 8.5% | 29.6% | 76.3% | CHEF 274% · USFD 223% · ANDE 146% |
| Consumer Staples Merchandise Retail | 12 | 3.4% | 32.6% | 62.4% | NGVC 185% · WMT 147% · PSMT 132% |
| Tobacco | 6 | -12.5% | 15.4% | 59.9% | PM 132% · TPB 95% · MO 95% |
| Food Retail | 6 | -22.2% | 73.0% | 43.4% | CASY 334% · SFM 255% · KR 45% |
| Soft Drinks & Non-alcoholic Beverages | 12 | -7.0% | -15.7% | 9.0% | COKE 382% · BRFH 344% · CCHGY 106% |
| Brewers | 3 | -15.1% | -28.3% | -3.4% | BUD 37% · TAP -3% · SAM -71% |
| Agricultural Products & Services | 12 | 13.4% | -2.5% | -15.9% | BG 61% · ADM 47% · INGR 35% |
| Personal Care Products | 4 | -8.3% | -30.1% | -26.2% | ELF 210% · PG 14% · COTY -67% |
| Household Products ← | 20 | 4.9% | -4.4% | -27.2% | IPAR 80% · ACU 69% · CL 31% |
| Packaged Foods & Meats | 48 | -17.4% | -33.6% | -36.7% | MAMA 573% · LWAY 400% · SENEA 279% |
| Distillers & Vintners | 6 | -37.6% | -61.9% | -76.4% | STZ -31% · BF-B -55% · MGPI -71% |
| Drug Retail | 3 | -35.8% | -84.3% | -92.0% | HITI -68% · PETS -92% · SCNX -99% |
Median of constituents with a full price history over each window. Top names are unfiltered by size in this render.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Acme United Earnings Notes | 12/16/2025 | |
| Is Acme United Stock Built to Withstand a Pullback? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 75.95 |
| Mkt Cap | 3.8 |
| Rev LTM | 3,084 |
| Op Inc LTM | 259 |
| FCF LTM | 346 |
| FCF 3Y Avg | 319 |
| CFO LTM | 390 |
| CFO 3Y Avg | 363 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.9% |
| Rev Chg 3Y Avg | 3.2% |
| Rev Chg Q | 2.1% |
| QoQ Delta Rev Chg LTM | 0.5% |
| Op Inc Chg LTM | -6.6% |
| Op Inc Chg 3Y Avg | 3.0% |
| Op Mgn LTM | 15.2% |
| Op Mgn 3Y Avg | 15.6% |
| QoQ Delta Op Mgn LTM | -0.1% |
| CFO/Rev LTM | 17.1% |
| CFO/Rev 3Y Avg | 12.5% |
| FCF/Rev LTM | 11.2% |
| FCF/Rev 3Y Avg | 10.1% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| First Aid and Medical | 130 | 119 | 114 | 105 | 92 |
| Cutting and Sharpening | 67 | 75 | 77 | 89 | 91 |
| Total | 197 | 194 | 192 | 194 | 182 |
| $ Mil | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| United States | 7 | 7 | 5 | 4 | 3 |
| Europe | 0 | 0 | 0 | 0 | -0 |
| Canada | 0 | 1 | 1 | 1 | 1 |
| Total | 7 | 7 | 6 | 5 | 4 |
| $ Mil | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| United States | 74 | 71 | 57 | 56 | 43 |
| Europe | 4 | 4 | 6 | 6 | 6 |
| Canada | 4 | 4 | 5 | 6 | 6 |
| Total | 81 | 79 | 68 | 68 | 55 |
Price Behavior
Price Behavior
| Market Price | $59.59 | |
| Market Cap ($ Bil) | 0.2 | |
| First Trading Date | 09/07/1984 | |
| Distance from 52W High | -0.5% | |
| 50 Days | 200 Days | |
| DMA Price | $49.25 | $43.41 |
| DMA Trend | up | up |
| Distance from DMA | 21.0% | 37.3% |
| 3M | 1YR | |
| Volatility | 41.7% | 35.0% |
| Downside Capture | -130.18 | 42.11 |
| Upside Capture | 64.66 | 71.01 |
| Correlation (SPY) | -26.0% | 14.3% |
ACU Betas & Captures as of 7/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -2.42 | -0.91 | -0.61 | 0.20 | 0.44 | 0.59 |
| Up Beta | -5.76 | -2.44 | -1.89 | -0.01 | 0.73 | 0.88 |
| Down Beta | -4.46 | -0.98 | -1.00 | -0.33 | -0.30 | 0.37 |
| Up Capture | 61% | 59% | 73% | 72% | 69% | 30% |
| Bmk +ve Days | 11 | 22 | 35 | 67 | 138 | 427 |
| Stock +ve Days | 14 | 26 | 35 | 62 | 119 | 349 |
| Down Capture | -238% | -159% | -105% | 12% | 54% | 71% |
| Bmk -ve Days | 11 | 21 | 28 | 59 | 114 | 326 |
| Stock -ve Days | 8 | 17 | 28 | 63 | 132 | 395 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ACU | |
|---|---|---|---|---|
| ACU | 45.0% | 35.1% | 1.11 | - |
| Sector ETF (XLP) | 5.4% | 14.1% | 0.14 | 18.2% |
| Equity (SPY) | 22.6% | 12.8% | 1.32 | 14.1% |
| Gold (GLD) | 31.4% | 28.4% | 0.95 | -6.8% |
| Commodities (DBC) | 37.9% | 20.1% | 1.48 | -19.7% |
| Real Estate (VNQ) | 14.3% | 13.8% | 0.73 | 27.2% |
| Bitcoin (BTCUSD) | -46.5% | 42.9% | -1.33 | 10.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ACU | |
|---|---|---|---|---|
| ACU | 9.5% | 41.0% | 0.33 | - |
| Sector ETF (XLP) | 6.4% | 13.6% | 0.26 | 9.8% |
| Equity (SPY) | 13.4% | 17.2% | 0.60 | 17.3% |
| Gold (GLD) | 19.0% | 18.6% | 0.83 | -3.0% |
| Commodities (DBC) | 9.8% | 19.6% | 0.39 | 0.1% |
| Real Estate (VNQ) | 2.2% | 18.9% | 0.01 | 19.1% |
| Bitcoin (BTCUSD) | 9.9% | 52.8% | 0.37 | 6.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ACU | |
|---|---|---|---|---|
| ACU | 12.9% | 42.5% | 0.43 | - |
| Sector ETF (XLP) | 7.3% | 14.8% | 0.36 | 8.4% |
| Equity (SPY) | 15.4% | 17.9% | 0.73 | 15.8% |
| Gold (GLD) | 12.0% | 16.2% | 0.61 | -1.7% |
| Commodities (DBC) | 8.0% | 18.0% | 0.36 | 2.1% |
| Real Estate (VNQ) | 4.7% | 20.7% | 0.19 | 15.3% |
| Bitcoin (BTCUSD) | 60.9% | 66.1% | 1.01 | 6.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 8/3/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 7/23/2026 | 14.3% | 30.5% | |
| 4/23/2026 | -4.5% | -9.7% | -5.1% |
| 2/26/2026 | 0.9% | -3.0% | -2.5% |
| 10/21/2025 | -1.8% | 1.3% | -7.3% |
| 7/23/2025 | 4.3% | 2.3% | -4.2% |
| 4/17/2025 | 3.2% | 5.3% | -0.7% |
| 2/28/2025 | -4.3% | -4.6% | 1.7% |
| 10/18/2024 | -1.3% | -2.3% | 1.1% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 12 | 13 | 8 |
| # Negative | 12 | 11 | 15 |
| Median Positive | 4.1% | 4.5% | 13.1% |
| Median Negative | -2.8% | -4.6% | -5.1% |
| Max Positive | 14.3% | 30.5% | 33.0% |
| Max Negative | -10.3% | -16.0% | -13.2% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 7/23/2026 | 14.3% | 30.5% | |
| 4/23/2026 | -4.5% | -9.7% | -5.1% |
| 2/26/2026 | 0.9% | -3.0% | -2.5% |
| 10/21/2025 | -1.8% | 1.3% | -7.3% |
| 7/23/2025 | 4.3% | 2.3% | -4.2% |
| 4/17/2025 | 3.2% | 5.3% | -0.7% |
| 2/28/2025 | -4.3% | -4.6% | 1.7% |
| 10/18/2024 | -1.3% | -2.3% | 1.1% |
| 7/19/2024 | 3.9% | 4.5% | 9.9% |
| 4/19/2024 | -10.3% | -5.5% | -8.9% |
| 3/1/2024 | -7.0% | -16.0% | -0.8% |
| 10/23/2023 | 2.0% | 6.9% | 33.0% |
| 7/21/2023 | 4.9% | 3.3% | 21.8% |
| 4/21/2023 | 8.3% | 6.1% | -0.5% |
| 3/2/2023 | 2.2% | 3.8% | -7.4% |
| 10/21/2022 | -9.1% | -7.3% | -2.1% |
| 7/22/2022 | -0.1% | -10.1% | -13.2% |
| 4/22/2022 | -3.8% | -3.5% | -5.3% |
| 3/1/2022 | 2.6% | -2.1% | -0.2% |
| 10/26/2021 | -0.2% | 4.6% | -10.5% |
| 7/22/2021 | -0.7% | -2.6% | -8.4% |
| 4/19/2021 | 6.0% | 19.9% | 16.4% |
| 3/3/2021 | -1.3% | 2.1% | 4.5% |
| 10/21/2020 | 5.6% | 4.2% | 32.6% |
| SUMMARY STATS | |||
| # Positive | 12 | 13 | 8 |
| # Negative | 12 | 11 | 15 |
| Median Positive | 4.1% | 4.5% | 13.1% |
| Median Negative | -2.8% | -4.6% | -5.1% |
| Max Positive | 14.3% | 30.5% | 33.0% |
| Max Negative | -10.3% | -16.0% | -13.2% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/06/2026 | 10-Q |
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 03/11/2026 | 10-K |
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/06/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 03/06/2025 | 10-K |
| 09/30/2024 | 11/08/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/08/2024 | 10-Q |
| 12/31/2023 | 03/07/2024 | 10-K |
| 09/30/2023 | 11/08/2023 | 10-Q |
| 06/30/2023 | 08/08/2023 | 10-Q |
| 03/31/2023 | 05/09/2023 | 10-Q |
| 12/31/2022 | 03/10/2023 | 10-K |
| 09/30/2022 | 11/09/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/06/2026 | 10-Q |
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 03/11/2026 | 10-K |
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/06/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 03/06/2025 | 10-K |
| 09/30/2024 | 11/08/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/08/2024 | 10-Q |
| 12/31/2023 | 03/07/2024 | 10-K |
| 09/30/2023 | 11/08/2023 | 10-Q |
| 06/30/2023 | 08/08/2023 | 10-Q |
| 03/31/2023 | 05/09/2023 | 10-Q |
| 12/31/2022 | 03/10/2023 | 10-K |
| 09/30/2022 | 11/09/2022 | 10-Q |
| 06/30/2022 | 08/08/2022 | 10-Q |
| 03/31/2022 | 05/09/2022 | 10-Q |
| 12/31/2021 | 03/30/2022 | 10-K |
| 09/30/2021 | 11/09/2021 | 10-Q |
| 06/30/2021 | 08/06/2021 | 10-Q |
| 03/31/2021 | 05/07/2021 | 10-Q |
| 12/31/2020 | 03/31/2021 | 10-K |
| 09/30/2020 | 11/06/2020 | 10-Q |
| 06/30/2020 | 08/10/2020 | 10-Q |
| 03/31/2020 | 05/08/2020 | 10-Q |
| 12/31/2019 | 03/13/2020 | 10-K |
| 09/30/2019 | 11/07/2019 | 10-Q |
Industry Resources
| Consumer Staples Resources |
| FoodNavigator |
| Consumer Goods Technology (CGT) |
| Beverage Digest |
| Household Products Resources |
| Happi (Household and Personal Products Industry) |
| Nonwovens Industry |
| Consumer Reports - Household Products |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.
Core Cache Last Updated: 8/12/2026